Heidi Paquette
Nurse Practitioner · Savannah, GANPI 1477196053
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,529 of the $3,962 with a category attached, or 89.1%. It is spread thinly across 21 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,871 and has fallen 70.8% since, to $546 in 2025. Among nurse practitioner clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 182 payments — averaging $21.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Travere Therapeutics, Inc.$536
- AstraZeneca$525
- Amgen$417
- OPKO Pharmaceuticals, LLC$413
- Bayer$412
- Otsuka America Pharmaceutical, Inc.$260
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,52989%
- Education$43311%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Travere Therapeutics, Inc. | 29 | $536 |
| AstraZeneca | 23 | $525 |
| Amgen(2 entities) | 21 | $417 |
| OPKO Pharmaceuticals, LLC | 20 | $413 |
| Bayer | 20 | $412 |
| Otsuka America Pharmaceutical, Inc. | 12 | $260 |
| Novartis | 11 | $244 |
| Aurinia Pharma U.S., Inc. | 6 | $212 |
| Vifor Pharma, Inc. | 9 | $207 |
| Ardelyx, Inc. | 4 | $183 |
| Mallinckrodt Hospital Products Inc. | 6 | $142 |
| ANI Pharmaceuticals, Inc. | 5 | $92 |
| Calliditas Therapeutics US Inc. | 4 | $82 |
| Novo Nordisk | 3 | $62 |
| Lilly USA, LLC | 2 | $35 |
| Fresenius USA Marketing, Inc. | 2 | $33 |
| Organon | 1 | $26 |
| Mayne Pharma Commercial LLC | 1 | $25 |
| GSK | 1 | $24 |
| Averitas Pharma Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,962 in reported general payments places this provider in the 90th percentile of 3,328 nurse practitioner providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 119 | $86,683 |
| RayaldeeCalcifediol | 62 | $76,958 |
| JardianceEmpagliflozin | 52 | $40,516 |
| KerendiaFinerenone | 43 | $30,734 |
| VeltassaPatiromer Calcium Sorbitex | 15 | $15,124 |
| OzempicSemaglutide | 11 | $11,783 |
| Olmesartan-Amlodipine-HctzOlmesartan/Amlodipin/Hcthiazid | 44 | $6,552 |
| Telmisartan-AmlodipineTelmisartan/Amlodipine | 38 | $5,488 |
| Olmesartan Medoxomil | 126 | $1,599 |
| Amlodipine-OlmesartanAmlodipine Bes/Olmesartan Med | 56 | $1,153 |
| Allopurinol | 104 | $1,019 |
| Spironolactone | 93 | $974 |
| Valsartan | 43 | $724 |
| Telmisartan | 51 | $675 |
| Carvedilol | 87 | $554 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $525 | $86,683119 claims |
| OPKO Pharmaceuticals, LLCRayaldee | $413 | $76,95862 claims |
| BayerKerendia | $412 | $30,73443 claims |
| Novo NordiskOzempic | $62 | $11,78311 claims |
| ANI Pharmaceuticals, Inc.Valsartan | $92 | $72443 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,328 nurse practitioner providers in Georgia.
Other nurse practitioner in Savannah
- Jessica AdkinsSavannah$226K
- Luis PoloSavannah$70K
- Wallette WidenerSavannah$20K
- Angie MoyeSavannah$14K
- Amy CarterSavannah$11K
- Mary RockwellSavannah$9K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Tajuana BradleyJohns Creek$256K
- Janice McAlisterAtlanta$221K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.